Acute myeloid leukaemia (AML) Funding required: $563,118 Currently raised: $30,745 Acute myeloid leukaemia (AML) A highly fatal blood cancer in adults and children. By adding a newly developed NAMPT inhibitor to standard of care treatment, this project can pave the way towards a more effective treatment of poor outcome adult and paediatric AML.
Improving brain cancer treatments Funding required: $400,000 Currently raised: $355,000 Paediatric high-grade glioma (HGG) This project focuses on improving treatment and survival for children with some of the most high-risk brain cancers
Supporting clinical trials Funding required: $750,000 Currently raised: $66,444 Providing access to international clinical trials and additional clinical trial expertise ANZCHOG international trials set up and manage the clinical trials for bran new kids' cancer treatments, giving kids access to the very latest therapies.
Recovering from treatment Funding required: $300,000 Currently raised: $72,800 RECOVER – Responding to late effects in survivors of childhood cancer Empowering young survivors of childhood cancer to transition to adulthood with the knowledge, skills and resources required to manage their ongoing health needs.
Tackling the effects of treatment Funding required: $305,000 Currently raised: $33,094 Treatment toxicity can cause infertility Developing genetic risk prediction of long term infertility from childhood cancer therapies leading to informed decisions and application of preventive measures.
Translating research Funding required: $186,000 Currently raised: $186,000 Sarcoma (bone & soft tissue cancer) Clinical translation of laboratory tested CAR T cell therapy into Phase 1 trials for paediatric treatment of sarcoma.